Nadian Bio develops cancer drugs with a focus on providing neutropenia medications, anti-cancer combination therapy, and treatments for aging-related diseases.

Vision and Mission: The company’s vision is to enhance the therapeutic effect of existing drugs while reducing their side effects, thereby improving patient care.

Noteworthy Points:

• Founded in 2016, Nadian Bio is at the forefront of cancer and aging disease treatment.
• The company is involved in clinical trials, indicating a commitment to evidence-based therapies.
• Nadian Bio is backed by investors including Korea University Holdings.

The GICS industry group for Nadian Bio would be Biotechnology within the Health Care sector².

And a 20-word business pitch for Nadian Bio could be: “Empowering cancer care with Nadian Bio’s innovative therapies, reducing treatment side effects, and enhancing life quality for patients.”